Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003, Lisbon, Portugal.
Biofilmcenter, Deutsches Herzzentrum Berlin, Charité-Universitätsmedizin Berlin, Hindenburgdamm 30, 12203, Berlin, Germany.
AAPS PharmSciTech. 2018 May;19(4):1625-1636. doi: 10.1208/s12249-018-0974-7. Epub 2018 Feb 27.
Eradication of Gram-positive biofilms is a critical aspect in implant-associated infection treatment. Although antibiotic-containing particulate carriers may be a promising strategy for overcoming biofilm tolerance, the assessment of their interaction with biofilms has not been fully explored. In the present work, the antibiofilm activity of daptomycin- and vancomycin-loaded poly(methyl methacrylate) (PMMA) and PMMA-Eudragit RL 100 (EUD) microparticles against methicillin-resistant Staphylococcus aureus (MRSA) and polysaccharide intercellular adhesin-positive S. epidermidis biofilms was investigated using isothermal microcalorimetry (IMC) and fluorescence in situ hybridization (FISH). The minimal biofilm inhibitory concentrations (MBIC) of MRSA biofilms, as determined by IMC, were 5 and 20 mg/mL for daptomycin- and vancomycin-loaded PMMA microparticles, respectively. S. epidermidis biofilms were less susceptible, with a MBIC of 20 mg/mL for daptomycin-loaded PMMA microparticles. Vancomycin-loaded microparticles were ineffective. Adding EUD to the formulation caused a 4- and 16-fold reduction of the MBIC values of daptomycin-loaded microparticles for S. aureus and S. epidermidis, respectively. FISH corroborated the IMC results and provided additional insights on the antibiofilm effect of these particles. According to microscopic analysis, only daptomycin-loaded PMMA-EUD microparticles were causing a pronounced reduction in biofilm mass for both strains. Taken together, although IMC indicated that a biofilm inhibition was achieved, microscopy showed that the biofilm was not eradicated and still contained FISH-positive, presumably viable bacteria, thus indicating that combining the two techniques is essential to fully assess the effect of microparticles on staphylococcal biofilms.
消除革兰氏阳性生物膜是治疗植入物相关感染的一个关键方面。尽管含抗生素的颗粒载体可能是克服生物膜耐受性的一种有前途的策略,但它们与生物膜的相互作用尚未得到充分探索。在本工作中,使用等温微量量热法(IMC)和荧光原位杂交(FISH)研究了载有万古霉素和达托霉素的聚甲基丙烯酸甲酯(PMMA)和 PMMA-Eudragit RL 100(EUD)微球对抗耐甲氧西林金黄色葡萄球菌(MRSA)和多糖细胞间黏附阳性表皮葡萄球菌生物膜的抗生物膜活性。通过 IMC 测定,MRSA 生物膜的最小生物膜抑制浓度(MBIC)分别为 5 和 20 mg/mL 载有达托霉素和万古霉素的 PMMA 微球。表皮葡萄球菌生物膜的敏感性较低,载有达托霉素的 PMMA 微球的 MBIC 为 20 mg/mL。载有万古霉素的微球无效。在制剂中添加 EUD 可使载有达托霉素的微球对金黄色葡萄球菌和表皮葡萄球菌的 MBIC 值分别降低 4 倍和 16 倍。FISH 证实了 IMC 的结果,并提供了这些颗粒抗生物膜作用的更多见解。根据显微镜分析,只有载有达托霉素的 PMMA-EUD 微球才能显著减少两种菌株的生物膜质量。综上所述,尽管 IMC 表明生物膜抑制已达到,但显微镜观察表明生物膜并未被根除,仍然含有 FISH 阳性的、可能存活的细菌,这表明结合这两种技术对于充分评估微球对葡萄球菌生物膜的影响至关重要。